Stories & News

Congratulations to Our Lupus Advocates

Your Hard Work is Working for Lupus Research Millions in funding specifically for lupus research – championed throughout the year by...

2017 Lupus Insight Prize Presented to Dr. Virginia Pascual

Funds Major Study of Lupus Biomarkers to Predict Flares The 2017 Lupus Insight Prize was awarded on June 15th to Virginia...

The Who, What, Why’s of Lupus

Three lupus experts from Jacobi Medical Center answered these common questions at an educational seminar co-sponsored by the Lupus Research...

Advancing Lupus Care Through Research and Advocacy Conference

The First Collaborative Conference a Great Success The Lupus Research Alliance and Lupus Foundation New England recently co-hosted the Advancing Lupus...

Make Your Voice Heard on Lupus Drug Development

The national lupus patient advocacy community is excited to announce that people with lupus will have the chance to be part...

Novel Research Grants Push Discoveries

10 New Grants, 10 New Insights The path to safe and effective treatments and ultimately a cure lies in bold, pioneering...

Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global immunology...